Skin and cosmetic evidence
If GHK-Cu has a flagship use backed by real human data, it is topical skin care.
The largest body of human evidence GHK-Cu has
If GHK-Cu has a flagship use backed by real human data, it is topical skin care. Several controlled studies, including a randomized double-blind trial, report measurable improvements in wrinkles, firmness, and skin density from copper-peptide creams. This is where the most human studies sit, though the single strongest individual trial is the diabetic-ulcer study in the wounds unit.
This unit walks the best skin trials, the fibroblast mechanism that explains them, and a fair comparison with retinol. It is the high-water mark of the evidence, and it is still cosmetic-grade, which is an important boundary to keep.
Key terms
The wrinkle trial numbers
The most-cited cosmetic wrinkle result reports that a GHK-Cu cream in a nano-lipid carrier reduced wrinkle volume and depth versus control, and beat a peptide comparator, in 40 women aged 40 to 65 over 8 weeks. It was run split-face: every participant put the GHK-Cu serum on the right side of her face and a comparator or a plain vehicle on the left, so each woman acted as her own control. It is worth knowing but not worth leaning on: it appeared in a low-quality journal and falls well short of a rigorous, independently replicated trial.
This is real, controlled human evidence, which is rare for any peptide. The honest framing is that it is a small, short, cosmetic-endpoint trial of one formulation, strong enough to take seriously and not strong enough to generalize to every cream or claim.
AdvancedWhat "double-blind" buys you here
The report describes randomizing 40 women aged 40 to 65 with blinding, but it was published in a predatory-tier journal, is small and short (eight weeks), and has not been independently replicated. The split-face setup is a real strength, since it removes differences between people from the comparison. It also has a catch worth naming: the treated side was the right side for everyone, so side of the face is bundled together with treatment rather than shuffled. Read its wrinkle-volume numbers as a weak signal that still needs confirmation, not as established proof. The genuinely strong human GHK-Cu evidence is elsewhere, in the diabetic-ulcer wound trial, not in cosmetic wrinkle studies.